Diagnostic News and Research

RSS

Journal of Pediatric Surgery Case Reports from Elsevier

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the launch of Journal of Pediatric Surgery Case Reports (JPS Case Reports), a new online-only, open access journal devoted to the rapid publication of short, precise reports in pediatric surgery.

18 Dec 2012

LSDF announces five new grants to support commercial development of health-care products

The Life Sciences Discovery Fund (LSDF) today announced over $1 million in five awards to support commercial development of new health and health-care products within both the non-profit and for-profit sectors in Washington.

18 Dec 2012

University of Leicester autism expert contributes to international global health study

A leading international expert on autism at the University of Leicester has been involved in contributing to a major new study of global health.

18 Dec 2012

Survey shows health care costs projected to increase at slower pace

Projected cost increases for all types of medical plans are anticipated to be down by between 0.2 and 0.6 percent through the first half of 2013, according to a survey by Buck Consultants, A Xerox Company.

17 Dec 2012

Range of epigenetic immunoassays from VolitionRx now available for research use

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests, announces the launch of NuQ, its range of research use only epigenetic immunoassays, to be available for sale at www.nucleosomics.com.

17 Dec 2012

Study describes new, paradoxical characteristics of HER2-negative breast cancer

A multicenter study led by researchers at UC Davis describes new, paradoxical characteristics of the most common type of breast cancer. The findings shed light on how the disease can evade treatment and could improve diagnosis and treatment of breast cancer.

15 Dec 2012

New diagnostic innovations could refine the way doctors detect prostate cancer

Despite the volume of prostate cancer tests and treatments, experts and their patients are continually challenged to predict the disease's course and apply the most appropriate treatment. Now, two new diagnostic innovations – the PCA3 urine test and a more targeted prostate biopsy technique - could refine the way doctors diagnose prostate cancer and, subsequently, the way patients elect to treat it.

15 Dec 2012

Fluidigm, GIS announce establishment of first single-cell genomics research center in Asia

The Genome Institute of Singapore (GIS), an institute under the umbrella of the Agency for Science, Technology and Research, and Fluidigm Corporation today announced the establishment of the first research center in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells.

15 Dec 2012

MDx, Amarantus sign license agreement for LymPro Alzheimer's disease diagnostic blood test

Amarantus BioScience, Inc., a biotechnology company discovering and developing treatments for diseases associated with protein misfolding and apoptosis, today announced that it has licensed the LymPro Alzheimer's Disease Diagnostic Blood Test (LymPro) from Memory Dx, LLC (MDx), formerly known as Provista Life Sciences, Inc.

14 Dec 2012

NCC to expand women's cancer programs in the developing world

The National Cancer Coalition (NCC) is expanding its efforts to fight women's cancers in the developing world.

14 Dec 2012

Novel antibodies can aid in early diagnosis of Sjogren's Syndrome

Patients suffering from the painful autoimmune disease, Sjogren's Syndrome, will soon be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at the University at Buffalo and Immco Diagnostics, Inc. The breakthrough, described in a paper in the December issue of Clinical Immunology, will allow patients to be treated sooner when they are much more likely to benefit.

14 Dec 2012

Longer looks: 'Reckless' drug prescriptions lead to patient deaths; The struggles to reopen NY hospitals

Dr. Carlos Estiandan was up to no good, and the medical board of California was on to him. He prescribed powerful painkillers to addicts who had no medical need for them, conducted sham examinations and appeared to be a key supplier for drug dealers, according to court records. He wrote more prescriptions than the entire staffs of some hospitals and took in more than $1 million a year.

14 Dec 2012

Scientists identify new mutation in a gene that causes Alpha-1 Antitrypsin Deficiency

Scientists have identified a new mutation in the gene that causes the inherited disease known as Alpha-1 Antitrypsin Deficiency (Alpha-1), which affects roughly one in 2,500 people of European descent.

14 Dec 2012

Concord Medical to acquire 19.98% ownership of MD Anderson Proton Therapy Center

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced the signing of a definitive agreement under which it will acquire 19.98% of indirect ownership of The University of Texas MD Anderson Cancer Center Proton Therapy Center (MD Anderson Proton Therapy Center), achieved through acquiring a minority interest in the general partner and facility manager.

13 Dec 2012

China SFDA approves Veridex’s CellSearch test for women with metastatic breast cancer

Veridex, LLC today announced approval from the China State Food & Drug Administration (SFDA) for the CellSearch circulating tumor cell (CTC) test as an in vitro diagnostic for women with metastatic breast cancer.

13 Dec 2012

TU Darmstadt’s biosensor can diagnose African sleeping sickness before it breaks out

African sleeping sickness is an infectious disease that is widespread south of the Sahara Desert. Although the around sixty million people residing in tropical Africa run the risk of becoming infected with the disease every day, only around four million of them are monitored for the disease by disease-control authorities.

13 Dec 2012

Mathematical models can improve efficiency and quality of healthcare

Healthcare organizations face huge challenges during the upcoming years: the constant cost increases must be halted, while at the same time patients are becoming more and more demanding, and hospitals nationwide still cope with some 2000 avoidable deaths each year. Simultaneously improving efficiency and quality of care would seem to be a contradiction in terms. Yet Kortbeek shows in his thesis, along a number of case studies, that this is absolutely doable. The key is developing and applying mathematical models.

13 Dec 2012

Bumetanide could treat children with severe autism or Asperger's syndrome

Although this therapy is not curative, it nevertheless reduced the autistic disorders' severity in three-quarters of the children. The researchers have filed a request for authorisation to perform a multi-centre European clinical trial in order to determine more precisely the population concerned by this therapy.

13 Dec 2012

New listening device monitors effectiveness of kidney stone treatment

A new listening device, developed by scientists from the University of Southampton, is being used to monitor the effectiveness of the treatment of kidney stones - saving patients unnecessary repeat therapy and x-ray monitoring.

13 Dec 2012

New diagnostic assay for screening ALK fusions in non-small cell lung carcinoma

Approximately one in 20 patients with non-small cell lung carcinoma (NSCLC) has chromosomal aberrations targeting the anaplastic lymphoma kinase (ALK) gene. This has considerable implications for treatment because these patients are highly responsive to ALK-specific kinase inhibitors such as crizotinib.

From NanoString Technologies 13 Dec 2012

Diagnostic News and Research

Journal of Pediatric Surgery Case Reports from Elsevier

LSDF announces five new grants to support commercial development of health-care products

University of Leicester autism expert contributes to international global health study

Survey shows health care costs projected to increase at slower pace

Range of epigenetic immunoassays from VolitionRx now available for research use

Study describes new, paradoxical characteristics of HER2-negative breast cancer

New diagnostic innovations could refine the way doctors detect prostate cancer

Fluidigm, GIS announce establishment of first single-cell genomics research center in Asia

MDx, Amarantus sign license agreement for LymPro Alzheimer's disease diagnostic blood test

NCC to expand women's cancer programs in the developing world

Novel antibodies can aid in early diagnosis of Sjogren's Syndrome

Longer looks: 'Reckless' drug prescriptions lead to patient deaths; The struggles to reopen NY hospitals

Scientists identify new mutation in a gene that causes Alpha-1 Antitrypsin Deficiency

Concord Medical to acquire 19.98% ownership of MD Anderson Proton Therapy Center

China SFDA approves Veridex’s CellSearch test for women with metastatic breast cancer

TU Darmstadt’s biosensor can diagnose African sleeping sickness before it breaks out

Mathematical models can improve efficiency and quality of healthcare

Bumetanide could treat children with severe autism or Asperger's syndrome

New listening device monitors effectiveness of kidney stone treatment

New diagnostic assay for screening ALK fusions in non-small cell lung carcinoma

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News